| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 142,760 | 176,696 | 191,671 | 567,760 | | Cost of Revenue | 90,338 | 175,345 | 102,314 | 136,155 | | | Gross Profit | 52,422 | 1,351 | 89,357 | 431,605 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 16,166 | (44,835) | 76,513 | 65,625 | | Non Recurring |
-
| 5,126 | 729 | 41,636 | | Others | (32,946) | 108,510 | 31,223 | 29,412 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 35,654 | (67,450) | (19,108) | 294,932 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (102,059) | 2,443 | (621) | (42,561) | | Earnings Before Interest And Taxes | 32,485 | (63,811) | (19,834) | 250,559 | | Interest Expense | 20,003 | 24,788 | 19,173 | 18,048 | | Income Before Tax | 12,482 | (88,599) | (39,007) | 232,511 | | Income Tax Expense | 578 | (19,403) | (9,338) | 52,368 | | Minority Interest |
-
| (20) | 20 | 30 | | | | Net Income From Continuing Ops | 11,250 | (69,216) | (29,649) | 180,143 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 9,990 | (69,216) | (29,649) | 180,143 | | Preferred Stock And Other Adjustments | (1,710) | 1,710 |
-
|
-
| | | Net Income Applicable To Common Shares | $8,280 | ($67,506) | ($29,649) | $180,143 |
|
0.05% Nasdaq 
0.12%
Income Statement
